1. Home
  2. CCCC vs APEI Comparison

CCCC vs APEI Comparison

Compare CCCC & APEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • APEI
  • Stock Information
  • Founded
  • CCCC 2015
  • APEI 1991
  • Country
  • CCCC United States
  • APEI United States
  • Employees
  • CCCC N/A
  • APEI N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • APEI Other Consumer Services
  • Sector
  • CCCC Health Care
  • APEI Consumer Discretionary
  • Exchange
  • CCCC Nasdaq
  • APEI Nasdaq
  • Market Cap
  • CCCC 104.4M
  • APEI 453.1M
  • IPO Year
  • CCCC 2020
  • APEI 2007
  • Fundamental
  • Price
  • CCCC $1.43
  • APEI $31.07
  • Analyst Decision
  • CCCC Buy
  • APEI Buy
  • Analyst Count
  • CCCC 3
  • APEI 6
  • Target Price
  • CCCC $12.00
  • APEI $31.60
  • AVG Volume (30 Days)
  • CCCC 1.3M
  • APEI 334.1K
  • Earning Date
  • CCCC 07-31-2025
  • APEI 08-05-2025
  • Dividend Yield
  • CCCC N/A
  • APEI N/A
  • EPS Growth
  • CCCC N/A
  • APEI N/A
  • EPS
  • CCCC N/A
  • APEI 1.02
  • Revenue
  • CCCC $39,783,000.00
  • APEI $634,678,000.00
  • Revenue This Year
  • CCCC N/A
  • APEI $7.12
  • Revenue Next Year
  • CCCC N/A
  • APEI $4.17
  • P/E Ratio
  • CCCC N/A
  • APEI $29.98
  • Revenue Growth
  • CCCC 98.56
  • APEI 4.86
  • 52 Week Low
  • CCCC $1.09
  • APEI $11.80
  • 52 Week High
  • CCCC $7.66
  • APEI $31.62
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 50.43
  • APEI 59.37
  • Support Level
  • CCCC $1.36
  • APEI $28.57
  • Resistance Level
  • CCCC $1.63
  • APEI $30.95
  • Average True Range (ATR)
  • CCCC 0.14
  • APEI 1.21
  • MACD
  • CCCC -0.00
  • APEI 0.08
  • Stochastic Oscillator
  • CCCC 38.10
  • APEI 76.31

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About APEI American Public Education Inc.

American Public Education Inc provides online and campus based postsecondary education including various undergraduate and graduate degree programs. The fields of study include business administration, health science, technology, criminal justice, education, liberal arts, national security, military studies, intelligence, and homeland security. There are three reporting segments: the American Public University segment which is the key revenue generator; the Rasmussen University Segment and the Hondros College of Nursing segment. The revenue is generated from net course registrations and enrollment, tuition rate, net tuition, and other fees.

Share on Social Networks: